Robert McNamara - Feb 20, 2025 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: Director
Signature: Nicole Kelsey, by power of attorney
Stock symbol: RCEL
Transactions as of: Feb 20, 2025
Transactions value $: $100,900
Form type: 4
Date filed: 2/20/2025, 04:30 PM
Previous filing: Nov 15, 2024
Next filing: Mar 10, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Purchase	$101K	+10K	+27.97%	$10.09	45.7K	Feb 20, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $10.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares of Common Stock purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2	Includes unvested RSUs

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $10.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares of Common Stock purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Includes unvested RSUs